|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 739 out of 739 for Ada

<< First    < Previous  |  Next >    Last >>
0.011s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Brown JB
Year: 2008
Journal: Inflamm Bowel Dis
Title: Therapeutic benefit of pentostatin in severe IL-10-/- colitis.
Volume: 14
Issue: 7
Pages: 880-7
Publication
First Author: Blackburn MR
Year: 2003
Journal: J Clin Invest
Title: Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway.
Volume: 112
Issue: 3
Pages: 332-44
Publication
First Author: Mohamedali KA
Year: 1993
Journal: J Biol Chem
Title: The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine.
Volume: 268
Issue: 31
Pages: 23728-33
Publication
First Author: Orpinell M
Year: 2010
Journal: EMBO J
Title: The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates.
Volume: 29
Issue: 14
Pages: 2381-94
Publication
First Author: Apasov SG
Year: 1999
Journal: Int Immunol
Title: The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase.
Volume: 11
Issue: 2
Pages: 179-89
Publication
First Author: Stockinger EJ
Year: 2001
Journal: Nucleic Acids Res
Title: Transcriptional adaptor and histone acetyltransferase proteins in Arabidopsis and their interactions with CBF1, a transcriptional activator involved in cold-regulated gene expression.
Volume: 29
Issue: 7
Pages: 1524-33
Publication
First Author: Bieniasz PD
Year: 1997
Journal: EMBO J
Title: HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor.
Volume: 16
Issue: 10
Pages: 2599-609
Publication
First Author: Maier EA
Year: 2006
Journal: J Biol Chem
Title: Temporal regulation of enhancer function in intestinal epithelium: a role for Onecut factors.
Volume: 281
Issue: 43
Pages: 32263-71
Publication
First Author: Mistry D
Year: 2006
Journal: Osteoarthritis Cartilage
Title: The role of adenosine in chondrocyte death in murine osteoarthritis and in a murine chondrocyte cell line.
Volume: 14
Issue: 5
Pages: 486-95
Publication
First Author: Manalo JM
Year: 2020
Journal: FASEB J
Title: Adenosine A2B receptor: A pathogenic factor and a therapeutic target for sensorineural hearing loss.
Volume: 34
Issue: 12
Pages: 15771-15787
Protein
Organism: Mus musculus/domesticus
Length: 473  
Fragment?: false
Strain
Attribute String: F1 hybrid, mutant stock
Strain
Attribute String: mutant stock
Publication
First Author: Nascimento F
Year: 2015
Journal: Purinergic Signal
Title: Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.
Volume: 11
Issue: 4
Pages: 471-80
Publication
First Author: Ishikawa T
Year: 2001
Journal: Mutat Res
Title: Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies.
Volume: 477
Issue: 1-2
Pages: 41-9
Publication  
First Author: Gupta MK
Year: 2013
Journal: J Mol Cell Cardiol
Title: Functional dissection of myosin binding protein C phosphorylation.
Volume: 64
Pages: 39-50
Publication
First Author: Kulkarni AD
Year: 1992
Journal: Transplantation
Title: Immunohemopoietic effects of dietary nucleotide restriction in mice.
Volume: 53
Issue: 2
Pages: 467-72
Publication
First Author: Maier EA
Year: 2005
Journal: J Biol Chem
Title: Cdx binding determines the timing of enhancer activation in postnatal duodenum.
Volume: 280
Issue: 13
Pages: 13195-202
Publication
First Author: Wang L
Year: 2014
Journal: PLoS One
Title: Cardiac myosin binding protein C phosphorylation affects cross-bridge cycle's elementary steps in a site-specific manner.
Volume: 9
Issue: 11
Pages: e113417
Publication  
First Author: Sakaguchi AY
Year: 1984
Journal: Cytogenet Cell Genet
Title: Mouse proto-oncogene assignments (Abstracts of meeting presentations: Human gene mapping 7, Los Angeles Conference (1983) Seventh International Workshop on Human Gene Mapping)
Volume: 37 (1-4)
Pages: 573-574 (Abstr.) (399-616)
Protein
Organism: Mus musculus/domesticus
Length: 813  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 830  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 829  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 830  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 833  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 813  
Fragment?: false
Publication
First Author: Sterner DE
Year: 2002
Journal: Proc Natl Acad Sci U S A
Title: SALSA, a variant of yeast SAGA, contains truncated Spt7, which correlates with activated transcription.
Volume: 99
Issue: 18
Pages: 11622-7
Protein Domain
Type: Family
Description: The Mediator complex is a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. The Mediator complex, having a compact conformation in its free form, is recruited to promoters by direct interactions with regulatory proteins and serves for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. On recruitment the Mediator complex unfolds to an extended conformation and partially surrounds RNA polymerase II, specifically interacting with the unphosphorylated form of the C-terminal domain (CTD) of RNA polymerase II. The Mediator complex dissociates from the RNA polymerase II holoenzyme and stays at the promoter when transcriptional elongation begins. The Mediator complex is composed of at least 31 subunits: MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The subunits form at least three structurally distinct submodules. The head and the middle modules interact directly with RNA polymerase II, whereas the elongated tail module interacts with gene-specific regulatory proteins. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation.The head module contains: MED6, MED8, MED11, SRB4/MED17, SRB5/MED18, ROX3/MED19, SRB2/MED20 and SRB6/MED22. The middle module contains: MED1, MED4, NUT1/MED5, MED7, CSE2/MED9, NUT2/MED10, SRB7/MED21 and SOH1/MED31. CSE2/MED9 interacts directly with MED4. The tail module contains: MED2, PGD1/MED3, RGR1/MED14, GAL11/MED15 and SIN4/MED16. The CDK8 module contains: MED12, MED13, CCNC and CDK8. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP.Regulation of mRNA synthesis requires intermediary proteins that transduce regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Three types of intermediary factors that enable the basal transcription machinery to respond to transcriptional activator proteins bound to regulatory DNA sequences have been identified: (i) TAFIIs, which associate with TATA-binding protein (TBP) to form TFIID; (ii) mediator, which associates with RNA polymerase II to form a holo-polymerase; and (iii) coactivators such as human upstream stimulatory activity (USA), mammalian CBP/P300, yeast ADA complex, and HMG proteins. The interaction of these multiprotein complexes with activators and general transcription factors is essential for transcriptional regulation. This family of proteins represent the transcriptional mediator protein that is required for activation of many RNA polymerase II promoters and which are conserved from yeast to humans [].This entry represents the Med6 subunit of the Mediator complex in fungi.
Protein Domain
Type: Family
Description: The Mediator complex is a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. The Mediator complex, having a compact conformation in its free form, is recruited to promoters by direct interactions with regulatory proteins and serves for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. On recruitment the Mediator complex unfolds to an extended conformation and partially surrounds RNA polymerase II, specifically interacting with the unphosphorylated form of the C-terminal domain (CTD) of RNA polymerase II. The Mediator complex dissociates from the RNA polymerase II holoenzyme and stays at the promoter when transcriptional elongation begins. The Mediator complex is composed of at least 31 subunits: MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The subunits form at least three structurally distinct submodules. The head and the middle modules interact directly with RNA polymerase II, whereas the elongated tail module interacts with gene-specific regulatory proteins. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation.The head module contains: MED6, MED8, MED11, SRB4/MED17, SRB5/MED18, ROX3/MED19, SRB2/MED20 and SRB6/MED22. The middle module contains: MED1, MED4, NUT1/MED5, MED7, CSE2/MED9, NUT2/MED10, SRB7/MED21 and SOH1/MED31. CSE2/MED9 interacts directly with MED4. The tail module contains: MED2, PGD1/MED3, RGR1/MED14, GAL11/MED15 and SIN4/MED16. The CDK8 module contains: MED12, MED13, CCNC and CDK8. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP.Regulation of mRNA synthesis requires intermediary proteins that transduce regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Three types of intermediary factors that enable the basal transcription machinery to respond to transcriptional activator proteins bound to regulatory DNA sequences have been identified: (i) TAFIIs, which associate with TATA-binding protein (TBP) to form TFIID; (ii) mediator, which associates with RNA polymerase II to form a holo-polymerase; and (iii) coactivators such as human upstream stimulatory activity (USA), mammalian CBP/P300, yeast ADA complex, and HMG proteins. The interaction of these multiprotein complexes with activators and general transcription factors is essential for transcriptional regulation.This family of proteins represent the transcriptional mediator protein subunit 6 that is required for activation of many RNA polymerase II promoters and which are conserved from yeast to humans [].
Protein Domain
Type: Family
Description: The Mediator complex is a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. The Mediator complex, having a compact conformation in its free form, is recruited to promoters by direct interactions with regulatory proteins and serves for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. On recruitment the Mediator complex unfolds to an extended conformation and partially surrounds RNA polymerase II, specifically interacting with the unphosphorylated form of the C-terminal domain (CTD) of RNA polymerase II. The Mediator complex dissociates from the RNA polymerase II holoenzyme and stays at the promoter when transcriptional elongation begins. The Mediator complex is composed of at least 31 subunits: MED1, MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L, MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23, MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and CDC2L6/CDK11. The subunits form at least three structurally distinct submodules. The head and the middle modules interact directly with RNA polymerase II, whereas the elongated tail module interacts with gene-specific regulatory proteins. Mediator containing the CDK8 module is less active than Mediator lacking this module in supporting transcriptional activation.The head module contains: MED6, MED8, MED11, SRB4/MED17, SRB5/MED18, ROX3/MED19, SRB2/MED20 and SRB6/MED22. The middle module contains: MED1, MED4, NUT1/MED5, MED7, CSE2/MED9, NUT2/MED10, SRB7/MED21 and SOH1/MED31. CSE2/MED9 interacts directly with MED4. The tail module contains: MED2, PGD1/MED3, RGR1/MED14, GAL11/MED15 and SIN4/MED16. The CDK8 module contains: MED12, MED13, CCNC and CDK8. Individual preparations of the Mediator complex lacking one or more distinct subunits have been variously termed ARC, CRSP, DRIP, PC2, SMCC and TRAP.Regulation of mRNA synthesis requires intermediary proteins that transduce regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Three types of intermediary factors that enable the basal transcription machinery to respond to transcriptional activator proteins bound to regulatory DNA sequences have been identified: (i) TAFIIs, which associate with TATA-binding protein (TBP) to form TFIID; (ii) mediator, which associates with RNA polymerase II to form a holo-polymerase; and (iii) coactivators such as human upstream stimulatory activity (USA), mammalian CBP/P300, yeast ADA complex, and HMG proteins. The interaction of these multiprotein complexes with activators and general transcription factors is essential for transcriptional regulation. This family of proteins represent the transcriptional mediator protein that is required for activation of many RNA polymerase II promoters and which are conserved from yeast to humans [].This group represents a RNA polymerase II mediator complex, subunit 6, metazoa/plant types.
Publication
First Author: Lee YC
Year: 1997
Journal: Mol Cell Biol
Title: A transcriptional mediator protein that is required for activation of many RNA polymerase II promoters and is conserved from yeast to humans.
Volume: 17
Issue: 8
Pages: 4622-32
Protein
Organism: Mus musculus/domesticus
Length: 181  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 132  
Fragment?: true
Publication
First Author: Pray-Grant MG
Year: 2005
Journal: Nature
Title: Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation.
Volume: 433
Issue: 7024
Pages: 434-8
Publication
First Author: Pray-Grant MG
Year: 2002
Journal: Mol Cell Biol
Title: The novel SLIK histone acetyltransferase complex functions in the yeast retrograde response pathway.
Volume: 22
Issue: 24
Pages: 8774-86
Publication
First Author: Han Y
Year: 2014
Journal: EMBO J
Title: Architecture of the Saccharomyces cerevisiae SAGA transcription coactivator complex.
Volume: 33
Issue: 21
Pages: 2534-46
Publication
First Author: Ogryzko VV
Year: 1998
Journal: Cell
Title: Histone-like TAFs within the PCAF histone acetylase complex.
Volume: 94
Issue: 1
Pages: 35-44
Protein
Organism: Mus musculus/domesticus
Length: 246  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 195  
Fragment?: false